Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Desano Pharmaceutical is a leading Chinese pharmaceutical company specializing in the development and large-scale manufacture of anti-retroviral (ARV) drugs and active pharmaceutical ingredients (APIs). As a core subsidiary of the Acebright Group, the company has established a significant global footprint, providing affordable HIV/AIDS treatments to international markets and organizations such as the WHO, UNICEF, and USAID. Their portfolio includes a wide range of small molecule therapeutics targeting infectious diseases and oncology, supported by state-of-the-art manufacturing facilities that meet US FDA and EU GMP standards. Desano is recognized as one of the world's largest suppliers of ARV APIs, playing a vital role in global health initiatives through partnerships with the Medicines Patent Pool.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Desano Pharmaceutical.